Salem Erode Investments fixes Sept 3 record date for rights issue
- Record date fixed at September 3, 2026, for rights issue eligibility
- ISIN INE894E20010 assigned for rights entitlements in demat accounts
- Issue size remains up to ₹2,293.10 lakhs at ₹20 per share
- Rights entitlements credited before issue opens on September 15

*this image is generated using AI for illustrative purposes only.
Salem Erode Investments Limited has fixed September 3, 2026, as the record date for its proposed rights issue. This determines which shareholders are eligible to apply for the new equity shares.
The company also disclosed the International Securities Identification Number (ISIN) for the rights entitlements as INE894E20010. Eligible shareholders will receive these entitlements in their demat accounts prior to the issue opening date.
Rights Issue Details
The rights issue involves up to 1,14,65,520 equity shares at ₹20 per share, aggregating up to ₹2,293.10 lakhs. The issue is on a 1:1 basis to eligible shareholders.
| Parameter | Details |
|---|---|
| Issue Size | Up to 1,14,65,520 equity shares |
| Issue Price | ₹20 per share (₹19 premium) |
| Rights Entitlement | 1:1 ratio |
| Total Amount | Up to ₹2,293.10 lakhs |
| Record Date | September 3, 2026 |
| ISIN (Rights Entitlement) | INE894E20010 |
Tentative Schedule
The rights issue is scheduled to open on September 15, 2026. The last date for on-market renunciation is September 21, 2026, with the issue closing on September 25, 2026.
| Event | Date |
|---|---|
| Issue Opening Date | September 15, 2026 |
| Last Date for Renunciation | September 21, 2026 |
| Issue Closing Date | September 25, 2026 |
| Allotment Finalization | September 28, 2026 |
| Listing on BSE | September 29, 2026 |
Regulatory Compliance
The board approved the Letter of Offer and Application Form under the SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2018. The trading window for designated persons, closed since August 25, 2026, will reopen 48 hours after this disclosure.
Historical Stock Returns for Salem Erode Investments
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +3.33% | +3.33% | -5.81% | +0.53% | -16.50% | 0.0% |
How will the 1:1 rights issue ratio impact existing shareholders' equity dilution and earnings per share (EPS) in the short term?
What specific strategic initiatives or debt reduction plans is Salem Erode Investments allocating the ₹2,293.10 lakhs raised from this issue towards?
Given the ₹19 premium per share, how does this pricing compare to the current market valuation, and what does it signal about investor confidence?

































